Patents for C12P 21 - Preparation of peptides or proteins (112,499)
02/2000
02/24/2000CA2338386A1 Proteases and associated proteins
02/24/2000CA2338184A1 Bacterial superantigen vaccines
02/24/2000CA2280582A1 Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus
02/23/2000EP0980874A1 Process for production of insulin precursors having correctly linked cystein bridges
02/23/2000EP0980865A1 Physiologically active substance pf1191 and process for producing the same
02/23/2000EP0980436A1 Increased production of proteins by using chaperone-like proteins
02/23/2000EP0980434A1 Intracellular production of hepatitis c e1 and e2 truncated polypeptides
02/23/2000EP0980432A1 Chimeric opg polypeptides
02/23/2000EP0980429A2 Human toll-like receptor proteins, related reagents and methods
02/23/2000EP0980427A1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes
02/23/2000EP0980390A2 Human-cd28 specific monoclonal antibodies for antigen non-specific activation of t-lymphocytes
02/23/2000CN1245534A Mammalian cell surface antigens and relating reagents
02/23/2000CN1245533A Mammalian chemokines
02/23/2000CN1245502A DNA encoding lepidopteran-active delta-endotoxins and its use
02/23/2000CN1049686C Diagnostics and vaccines for hepatits virus non-A and non-B
02/23/2000CN1049663C Human progonoma necrosis factor
02/22/2000US6028250 For tissue-specific expression at site and stage for the reconstitution of plant cell wall xyloglucan; transgenic plants
02/22/2000US6028173 Amino acid sequence of polypeptide involved in axon outgrowth
02/22/2000US6028049 Compositions comprising the Tbp2 subunit of the transferrin receptor of Neisseria meningitidis
02/22/2000US6027935 Gene up-regulated in regenerating liver
02/22/2000US6027934 Nucleic acid and vectors encoding an immunodominant fragment of a unique protein antigen originally derived from trypanosoma brucei rhodesiense organisms can induce immunoprotection such as against trypanosomes, leishmania
02/22/2000US6027927 Human trk receptors and neurotrophic factor inhibitors
02/22/2000US6027922 Human foam cells and methods for preparing them, monoclonal antibodies to said foam cells and their pharmaceutical and diagnostic use
02/22/2000US6027920 System for protein expression and secretion especially in corynebacteria
02/22/2000US6027919 BMP-12 and BMP-13 proteins and DNA encoding them
02/22/2000US6027917 Bone morphogenetic protein (BMP)-17 and BMP-18 compositions
02/22/2000US6027915 Expression augmenting sequence elements (EASE) for eukaryotic expression systems
02/22/2000US6027911 Removing amino-terminal dipeptides from precursor polypeptide by immobilizing cathepsin c onto support surface, then incubating with polypeptide and recovering processed polypeptide
02/22/2000US6027905 Methods for the detection of cervical cancer
02/22/2000US6027896 Providing a prognosis in subjects previously diagnosed with alzheimer's by identifying the apolipoprotein e type isoforms; then providing prognosis based on the presence or absence of an apolipoprotein e type 4 (apoe4) isoform
02/22/2000US6027888 Methods for producing soluble, biologically-active disulfide-bond containing eukaryotic proteins in bacterial cells
02/22/2000US6027881 Mutant Aequorea victoria fluorescent proteins having increased cellular fluorescence
02/22/2000US6027878 A nucleic acid sequence; diagnosis of helicobacter infections, ulcers and gastrointestinal disorders
02/22/2000US6027875 Receptor infection assay
02/22/2000US6027874 Immunoenzymatic conjugate, method for its productions, applications thereof
02/22/2000US6027727 Inducing transient infertility in a mammal by administering a dose of recombinant zona pellicida proteins from a cat, cattle or cynomolgous monkey and human to stimulate antibody production; vaccines
02/22/2000US6027725 Multivalent antigen-binding proteins
02/22/2000CA2091882C Gene therapy for cystic fibrosis
02/22/2000CA1340910C Fibronectin binding protein
02/22/2000CA1340908C Methods of producing secreted receptor analogs and biologically active peptide dimers
02/22/2000CA1340906C Fibronectin binding protein as well as its preparation
02/22/2000CA1340903C Process for stabilizing a plasmid present in a bacterial strain and strain thus obtained
02/17/2000WO2000008206A1 A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer
02/17/2000WO2000008199A1 Molecular cloning of a 7tm receptor (gpr31a)
02/17/2000WO2000008197A1 Method for the production of an antibiotic agent
02/17/2000WO2000008182A1 Herpesvirus preparations and their uses
02/17/2000WO2000008181A2 Chp polypeptide, a ligand of pak65
02/17/2000WO2000008180A2 HUMAN cDNAs ENCODING POLYPEPTIDES HAVING KINASE FUNCTIONS
02/17/2000WO2000008179A1 Ikr-1 and ikr-2, protein kinases which are related to the i kappa b kinases
02/17/2000WO2000008178A2 Murine dna molecules encoding polypeptides having kinase functions
02/17/2000WO2000008174A1 β-CASEIN EXPRESSING CONSTRUCTS
02/17/2000WO2000008173A1 Identification and functional characterization of a novel ribosomal s6 protein kinase
02/17/2000WO2000008164A2 Thermostable in vitro complex with polymerase activity
02/17/2000WO2000008161A1 Transgenic plants with the expression of soybean glycinin
02/17/2000WO2000008158A2 Molecules designated ldcam
02/17/2000WO2000008154A1 Pancreatic and ovarian polypeptide, zsig58
02/17/2000WO2000008147A1 Genes involved in the molecular paths for tumour suppression and /or resistance to viruses
02/17/2000WO2000008144A1 Dna encoding a human inhibitor-of-apoptosis protein; hiap3
02/17/2000WO2000008142A2 Fibrous proteins and the production thereof
02/17/2000WO2000008139A1 Tumor necrosis factor-gamma
02/17/2000WO2000008133A1 NOVEL G PROTEIN-COUPLED RECEPTOR cDNA SEQUENCE
02/17/2000WO2000008053A1 Novel g-protein coupled receptor protein and dna thereof
02/17/2000WO2000008051A2 Immunological herpes simplex virus antigens and methods for use thereof
02/17/2000WO2000008043A2 Prevention and treatment of viral disease
02/17/2000WO2000007545A2 Apoptosis proteins
02/17/2000WO2000001815A3 Neurotrophic factors
02/17/2000WO1999051756A9 Promoter and constructions for expression of recombinant proteins in filamentous fungi
02/17/2000WO1999047923A9 Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof
02/17/2000DE19834909A1 Faserproteine und ihre Herstellung Fibrous proteins and their preparation
02/17/2000CA2362013A1 Transgenic plant expressing soybean glycinin
02/17/2000CA2347656A1 A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer
02/17/2000CA2339891A1 Chp polypeptide, a ligand of pak65
02/17/2000CA2339347A1 Novel g protein-coupled receptor cdna sequence
02/17/2000CA2339322A1 Genes involved in the molecular paths for tumour suppression and /or resistance to viruses
02/17/2000CA2339086A1 Dna replication- and repair-associated proteins
02/17/2000CA2338983A1 Prevention and treatment of viral disease
02/17/2000CA2338385A1 Human receptor-associated proteins
02/17/2000CA2338185A1 Thermostable in vitro complex with polymerase activity
02/17/2000CA2337968A1 Herpesvirus preparations and their uses
02/17/2000CA2337741A1 Pancreatic and ovarian polypeptide, zsig58
02/17/2000CA2336523A1 Immunological herpes simplex virus antigens and methods for use thereof
02/17/2000CA2336064A1 Fibrous proteins and the production thereof
02/17/2000CA2335648A1 A novel g protein-coupled receptor protein and its dna
02/17/2000CA2305308A1 Human cdnas encoding polypeptides having kinase functions
02/16/2000EP0979871A1 NOVEL dlg FAMILY MOLECULE, POLYNUCLEOTIDE ENCODING THE SAME, ANTIBODY AGAINST THE SAME, AND METHOD FOR DETECTING dlg GENE
02/16/2000EP0979870A1 Human Wnt-6 polypeptide
02/16/2000EP0979410A1 Method for determining cytokine receptor activation by the use of an antibody
02/16/2000EP0979295A1 Expression of fungicide-binding polypeptides in plants for producing fungicide tolerance
02/16/2000EP0979294A2 Gene conversion as a tool for the construction of recombinant industrial filamentous fungi
02/16/2000EP0979292A2 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety
02/16/2000EP0979291A1 Methods of production of an amidated peptide through the use of a fusion protein
02/16/2000EP0979282A1 Rat st38.2 chemokine
02/16/2000EP0979281A2 A method for making multispecific antibodies having heteromultimeric and common components
02/16/2000EP0979280A1 Polynucleotides encoding a cd53-like transmembrane protein
02/16/2000EP0979279A2 Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging
02/16/2000EP0979276A1 Complement receptor type 1 (cr1)-like sequences
02/16/2000EP0979271A1 Vascular adhesion protein-1 having amine oxidase activity
02/16/2000EP0979246A2 Man monoclonal antibodies to epidermal growth factor receptor
02/16/2000EP0979244A1 Novel cyclosporin derivatives, preparation and pharmaceutical compositions containing same
02/16/2000EP0979102A1 Polyalkylene oxide-modified single chain polypeptides